Usefulness of FFR in coronary bypass intermediate lesions

Original title: Long-term clinical outcome after fractional flow reserve– versus angio-guided percutaneous coronary intervention in patients with intermediate stenosis of coronary artery bypass grafts. Reference: Luigi Di Serafino et al. Am Heart J 2013;166:110-8.

Bypass coronary angioplasty is often preferred strategy versus re-operation , however it is associated with a greater number of events,  both short and long term, compared to native vessels angioplasty. The procedure is usually more difficult given the high amount of patient comorbidities and complexity of lesions so it is crucial to counterbalance the cost / benefit, especially in intermediate lesions .

The fractional flow reserve ( FFR ) has been shown to improve outcomes in native arteries but, so far there is no evidence to use it in coronary bypass. Intermediate lesions were considered those with a stenosis degree between 40% and 70% by visual estimation. We excluded patients with bypass tandem lesions, distal to the anastomosis native artery lesions and sequential bypass .

FFR branch guided patients received angioplasty only if FFR was ≤ 0.8. In total 223 patients were registered, of which 65  received FFR and 158  were guided by angiography. The injury rate in the FFR group has been more frequent in arterial bypasses and severity of intermediate lesions was higher in the angiography guided group.

In the FFR group , 23 patients ( 35 % ) received angioplasty (FFR 0.68 ± 0.09 ) and the rest, optimal medical treatment (FFR 0.92 ± 0.05, p = 0.01 versus those receiving angioplasty). In the angiography guided group , 90 patients ( 57 % ) underwent angioplasty ( % stenosis by quantitative angiography 56.8 ± 13.7 ) and the rest, medical treatment ( % stenosis by quantitative angiography 41.7 ± 9, p = 0.01 versus those receiving angioplasty). The FFR group received significantly fewer stents than the group guided by angiography. At follow-up at 3.8 years, FFR -guided group showed a lower rate of combined events (death, MI , stroke , revascularization ) than the angiographic group ( 28 versus 51% , HR 0.46, CI 0.28 – 0.77, P = 0.003 ) . This difference remained after making an adjustment using propensity score. The advantage of the FFR was primarily in the arterial bypass since the only saphenous vein bypass was considered, no differences were observed between groups.

Conclusion:

The FFR – guided revascularization in patients with prior CABG and arterial bypasses intermediate lesions resulted in better clinical outcomes compared to angiography guided . For intermediate vein graft lesions the results were similar between the two strategies .

Editorial Comment:

 

In the group guided by angiography venous grafts were significantly treated and these consecutively had lesions (whereas entering the intermediate definition ) with a greater percentage of stenosis to the group guided by FFR . This point could only explain the difference in events. 

SOLACI.ORG

More articles by this author

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

Coronary physiological assessment using pressure-wire techniques (FFR/iFR) carries a Class IA recommendation in ACC/AHA guidelines; however, its use remains limited due to factors such...

ACC 2026 | PRO-TAVI Trial: Deferring Coronary Angioplasty in Patients Undergoing TAVI

Coronary artery disease is common in patients with severe aortic stenosis undergoing TAVI. Current guidelines recommend considering revascularization in significant coronary lesions, particularly in...

ACC 2026 | CHIP-BCIS3: Impella use as support in high-risk complex PCI

The use of percutaneous ventricular support during high-risk complex PCI has been proposed as a strategy to prevent hemodynamic deterioration in patients with severe...

ACC 2026 | ORBITA-CTO: PCI in chronic total occlusions and stable angina — the randomized trial we were missing?

Percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) remains a topic of ongoing debate in stable angina, with persistent uncertainty regarding its role...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

Coronary physiological assessment using pressure-wire techniques (FFR/iFR) carries a Class IA recommendation in ACC/AHA guidelines; however, its use remains limited due to factors such...

ACC 2026 | Protect The Head-To-Head Trial: Randomized Comparison Between Emboliner and Sentinel During TAVI

Ischemic stroke remains one of the most feared complications of TAVI, with a relatively low but persistent incidence of 2–4%, without significant reduction over...

ACC 2026 | PRO-TAVI Trial: Deferring Coronary Angioplasty in Patients Undergoing TAVI

Coronary artery disease is common in patients with severe aortic stenosis undergoing TAVI. Current guidelines recommend considering revascularization in significant coronary lesions, particularly in...